Health care company Johnson & Johnson has been told to pay a Massachusetts teenager and her parents $63 million after she suffered a life-threatening drug reaction and lost most of her skin when she took a children's pain reliever nearly a decade ago. A Plymouth Superior Court jury Wednesday...
Researchers “cured” a strain of bacteria of its ability to resist an antibiotic in an experiment that has implications for a long-standing public health crisis.
Researchers have released an improved version of an online decision-support tool that has helped health-care providers adopt universal standards to identify materials, locations and partners within the U.S. health-care system.
A team of researchers has identified a protein with broad virus-fighting properties that potentially could be used as a weapon against deadly human pathogenic viruses such as HIV, Ebola, Rift Valley Fever, Nipah and others.
Young adults are often reluctant to seek treatment for mental health problems because of the stigma, inadequate insurance coverage and difficulty finding a mental health care provider, but a new study by suggests that depression symptoms may be significantly reduced when patients interact with computerized avatars— virtual 3D images of a healthcare provider like a nurse practitioner or physician— to rehearse office visits ahead of time and learn self-management skills.
MIT engineers have created genetic circuits in bacterial cells that not only perform logic functions, but also remember the results, which are encoded in the cell’s DNA and passed on for dozens of generations. The circuits could be used as long-term environmental sensors, efficient controls for biomanufacturing, or to program stem cells to differentiate into other cell types.
Enzymes, workhorse molecules of life that underpin almost every biological process, may have a new role as “intelligent” micro- and nanomotors with applications in medicine, engineering and other fields.
Vanderbilt biochemists have discovered that the process bacteria undergo when they become drug resistant can act as a powerful tool for drug discovery. Their findings should give a major boost to natural products drug discovery by substantially increasing the number of novel compounds that scientists can extract from individual microorganisms.
A team of researchers has discovered a way to stimulate the brain’s natural defense mechanisms in people with Alzheimer’s disease. This breakthrough opens the door to the development of a treatment for Alzheimer’s disease and a vaccine to prevent the illness.
Epigenetics research has expanded rapidly over the last several years, as evidenced by the exponential increase in published literature in this field. Breakthroughs have been made in the elucidation of basic epigenetic mechanisms such as histone modification, and with these advances have come an understanding of the critical role epigenetic modifications play in the development and progression of cancer.
Side effects are a major reason that drugs are taken off the market and a major reason why patients stop taking their medications, but scientists are now reporting the development of a new way to predict those adverse reactions ahead of time. The method could save patients from severe side effects and save drug companies time and money.
Merck KGaA announced the successful completion of its acquisition of Millipore. The closing follows the approval of the acquisition by Millipore’s shareholders and the satisfaction of other customary conditions, including antitrust clearance in the United States and Europe
Caliper Life Sciences, Inc. announced that its Caliper Discovery Alliances and Services unit has been awarded a new funding commitment for $2.9 million under its contract with the Environmental Protection Agency (EPA) for the EPA’s ToxCast screening program
AVI BioPharma, Inc. announced that it has been awarded a new contract for up to approximately $291 million total with the U.S. Department of Defense Chemical and Biological Defense Program through the U.S. Army Space and Missile Defense Command for the development of the Company's hemorrhagic fever virus therapeutic candidates, AVI-6002 and AVI-6003, for Ebola and Marburg viruses, respectively.
Asuragen, Inc. and Life Technologies Corporation announced that they have completed CE-marking and commercial launch in Europe of the BCR/ABL1 Quant Test, Asuragen's clinically validated and cGMP manufactured test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML)
According to IBM, DNA origami causes single DNA molecules to self assemble in solution via a reaction between a long single strand of viral DNA and a mixture of different short synthetic oligonucleotide strands.
It should come as no surprise to you all that your profession—science—is highly respected by the general public. I’m sure many of you expected this, but now there is validation in the form of a survey conducted by The Pew Research Center for the People and the Press.
Our industry is unique in that it is often only limited by the imagination of those working in it. If you can think of it and find funding (which often presents its own difficulties), then you can work on it.
Newly designed centerpieces used in the Beckman Coulter XL-A and XL-I instruments allow the systems to provide precise, repeatable measurement of pharmaceutical sample aggregation in pharmaceutical research and formulation laboratories.
Shimadzu Scientific Instruments introduces the AXIMA Resonance MALDI QIT TOF mass spectrometer for the structural characterization and sequencing of biomolecules.
The Waters SYNAPT G2 System features new QuanTof and enhanced High Definition MS technologies intended to accelerate scientists toward their research goals.
Pall Life Sciences has expanded its line of AcroSep chromatography columns (1 mL) to provide lab technicians with a full palette of color-coded columns that address the wide-range of chromatography separation requirements.
Waters introduced the first UltraPerformance LC (UPLC) analytical solution for the characterization of 2-AB labeled glycans from glycoproteins.
Beckman Coulter introduces advanced isoelectric focusing (IEF) technology, featuring a new peptide-based pI Marker Kit for the charge heterogeneity analysis of biotherapeutics.